Literature DB >> 3412894

Multiple nuclear factors interact with promoter sequences of the urokinase-type plasminogen activator gene.

D von der Ahe1, D Pearson, J Nakagawa, B Rajput, Y Nagamine.   

Abstract

To characterize proteins that bind to the cyclic AMP inducible promoter of the urokinase-type plasminogen activator gene, we performed a DNAase I footprinting analysis. Within 500 nucleotides upstream of the transcription start site we found eight protected regions due to at least four different binding proteins. Among these is a single binding site for the transcription factor CTF/NF1, which is flanked on each side by two conserved binding sites for the transcription factor Sp1. A region at -380, which shares a similarity with sequences observed in the corresponding regions of other cyclic AMP regulated genes, was protected. This binding site contains a sequence of ten nucleotides which is repeated further upstream at -480 and also protected against DNAase I digestion. Comparisons of extracts from four different cell lines revealed that all DNA binding factors are present in nuclei of uPA expressing and nonexpressing cells. Mechanism underlying hormonal regulation of the gene is discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3412894      PMCID: PMC338425          DOI: 10.1093/nar/16.15.7527

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  46 in total

1.  DNAse footprinting: a simple method for the detection of protein-DNA binding specificity.

Authors:  D J Galas; A Schmitz
Journal:  Nucleic Acids Res       Date:  1978-09       Impact factor: 16.971

2.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

3.  Preparation of homogeneous cyclic AMP-dependent protein kinase(s) and its subunits from rabbit skeletal muscle.

Authors:  J A Beavo; P J Bechtel; E G Krebs
Journal:  Methods Enzymol       Date:  1974       Impact factor: 1.600

4.  Genomic footprinting reveals cell type-specific DNA binding of ubiquitous factors.

Authors:  P B Becker; S Ruppert; G Schütz
Journal:  Cell       Date:  1987-11-06       Impact factor: 41.582

5.  Macrophage plasminogen activator: modulation of enzyme production by anti-inflammatory steroids, mitotic inhibitors, and cyclic nucleotides.

Authors:  J D Vassalli; J Hamilton; E Reich
Journal:  Cell       Date:  1976-06       Impact factor: 41.582

Review 6.  On the regulation and control of fibrinolysis. Edward Kowalski Memorial Lecture.

Authors:  D Collen
Journal:  Thromb Haemost       Date:  1980-06-18       Impact factor: 5.249

7.  The detection of DNA-binding proteins by protein blotting.

Authors:  B Bowen; J Steinberg; U K Laemmli; H Weintraub
Journal:  Nucleic Acids Res       Date:  1980-01-11       Impact factor: 16.971

8.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

9.  Secretion of plasminogen activator by human polymorphonuclear leukocytes. Modulation by glucocorticoids and other effectors.

Authors:  A Granelli-Piperno; J D Vassalli; E Reich
Journal:  J Exp Med       Date:  1977-12-01       Impact factor: 14.307

10.  Androgen-dependent fibrinolytic activity in a murine mammary carcinoma (Shionogi SC-115 cells) in vitro.

Authors:  T W Mak; G Rutledge; D J Sutherland
Journal:  Cell       Date:  1976-02       Impact factor: 41.582

View more
  10 in total

1.  The human skeletal alpha-actin gene is regulated by a muscle-specific enhancer that binds three nuclear factors.

Authors:  G E Muscat; S Perry; H Prentice; L Kedes
Journal:  Gene Expr       Date:  1992

2.  Isolation of novel cDNA encompassing the ADU balanced translocation break point in the DiGeorge critical region.

Authors:  M H Kim; H Hur; J Park; Y J Kim
Journal:  Mol Biotechnol       Date:  2001-03       Impact factor: 2.695

3.  Macromolecular interaction on a cAMP responsive region in the urokinase-type plasminogen activator gene: a role of protein phosphorylation.

Authors:  D von der Ahe; D Pearson; Y Nagamine
Journal:  Nucleic Acids Res       Date:  1990-04-25       Impact factor: 16.971

4.  Identification of an enhancer element for the endosperm-specific expression of high molecular weight glutenin.

Authors:  M S Thomas; R B Flavell
Journal:  Plant Cell       Date:  1990-12       Impact factor: 11.277

5.  Modulation of urokinase plasminogen activator system by poly(ADP-ribose)polymerase-1 inhibition.

Authors:  Josip Madunić; Mariastefania Antica; Petra Cvjetko; Lidija Požgaj; Maja Matulić
Journal:  Cytotechnology       Date:  2014-12-04       Impact factor: 2.058

6.  Constitutive expression of the urokinase plasminogen activator gene in murine RAW264 macrophages involves distal and 5' non-coding sequences that are conserved between mouse and pig.

Authors:  A I Cassady; K J Stacey; K A Nimmo; K M Murphy; D von der Ahe; D Pearson; F M Botteri; Y Nagamine; D A Hume
Journal:  Nucleic Acids Res       Date:  1991-12-25       Impact factor: 16.971

7.  A labile repressor acts through the NFkB-like binding sites of the human urokinase gene.

Authors:  U Novak; B G Cocks; J A Hamilton
Journal:  Nucleic Acids Res       Date:  1991-06-25       Impact factor: 16.971

Review 8.  Noncoding control region of naturally occurring BK virus variants: sequence comparison and functional analysis.

Authors:  U Moens; T Johansen; J I Johnsen; O M Seternes; T Traavik
Journal:  Virus Genes       Date:  1995       Impact factor: 2.332

9.  The antimetastatic effects of resveratrol on hepatocellular carcinoma through the downregulation of a metastasis-associated protease by SP-1 modulation.

Authors:  Chao-Bin Yeh; Ming-Ju Hsieh; Chiao-Wen Lin; Hui-Ling Chiou; Pen-Yuan Lin; Tzy-Yen Chen; Shun-Fa Yang
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

10.  Terminalia catappa attenuates urokinase-type plasminogen activator expression through Erk pathways in Hepatocellular carcinoma.

Authors:  Chao-Bin Yeh; Yung-Luen Yu; Chiao-Wen Lin; Hui-Ling Chiou; Ming-Ju Hsieh; Shun-Fa Yang
Journal:  BMC Complement Altern Med       Date:  2014-04-30       Impact factor: 3.659

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.